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ABSTRACT
Mammalian DNA methyltransferase 1 (DNMT1) is
essential for maintaining DNA methylation patterns
after cell division. Disruption of DNMT1 catalytic ac-
tivity results in whole genome cytosine demethyl-
ation of CpG dinucleotides, promoting severe
dysfunctions in somatic cells and during embryonic
development. While these observations indicate that
DNMT1-dependent DNA methylation is required for
proper cell function, the possibility that DNMT1 has
a role independent of its catalytic activity is a matter
of controversy. Here, we provide evidence that
DNMT1 can support cell functions that do not re-
quire the C-terminal catalytic domain. We report that
PCNA and DMAP1 domains in the N-terminal region
of DNMT1 are sufficient to modulate E-cadherin ex-
pression in the absence of noticeable changes in
DNA methylation patterns in the gene promoters
involved. Changes in E-cadherin expression are
directly associated with regulation of b-catenin-
dependent transcription. Present evidence suggests
that the DNMT1 acts on E-cadherin expression
through its direct interaction with the E-cadherin
transcriptional repressor SNAIL1.
INTRODUCTION
Methylation of the C-5 position of cytosine (5mC) in CpG
dinucleotides is a fundamental epigenetic mark of the
double-stranded DNA molecule. This chemical modiﬁca-
tion is directly involved in the structural transitions of the
chromatin ﬁber from open to closed conformations that
occur during chromatin compaction and transcriptional
repression (1,2). The speciﬁc transfer of methyl groups
to form 5mC is catalyzed by members of the DNA
methyltransferase (DNMT) protein family. Three classes
of DNMTs have been identiﬁed in mammals: DNMT1,
DNMT2 and DNMT3 (including DNMT3a, DNMT3b
and DNMT3L isoforms) (3,4). All of them share homolo-
gous catalytic domains but differ in their regulatory,
protein–DNA- and protein–protein-binding regions.
DNMT1 is the most abundant DNA methyltransferase
in mammalian somatic cells. This protein contains a large
C-terminal catalytic domain, and several regulatory motifs
in the N-terminal region, including the DMAP1- and
PCNA-binding domains (BAH1 and BAH2), a cysteine-
rich Zn-binding region, two bromo-adjacent homology
domains and a replication foci-targeting sequence
(Figure 1A). DNMT1 is actually present at functional
replication foci and has a strong preference for hemi-
methylated DNA. Therefore, it is considered to be the
enzyme that is primarily responsible for the essential func-
tions of copying and maintaining methylation patterns
from the parental to the daughter strand following DNA
replication (3).
Consistent with this concept, it has been demonstrated
that DNMT1 enzymatic activity is strictly required for
genomic imprinting and X chromosome inactivation dur-
ing mouse development (4). In mouse models, mutation of
both copies of the Dnmt1 gene resulted in a pronounced
failure to establish DNA methylation patterns in embry-
onic cells and subsequent embryonic lethality in mid-
gestation (5). Similar experiments in HCT116 human
colon cancer cells initially indicated that depletion of
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both full-length copies of the DNMT1 gene had no signiﬁ-
cant effect on DNA methylation or, therefore, on cell via-
bility (6). Surprisingly, these cells exhibited only a modest
reduction (<20%) in the whole genomic content of 5mC,
suggesting that DNMT1 activity is either dispensable in
human cells or rescued by another DNMT.
Further studies demonstrated that the original targeting
mutation strategy of skipping DNMT1 gene expression in
HCT116 cells actually led to a DNMT1 hypomorphyc
allele with a low level of catalytic activity (20% of
normal DNMT1 expression) (7,8). This hypomorph was
the product of alternative splicing of the DNMT1 gene
between exons 2 and 7, thus bypassing the knockout cas-
sette that replaced exons 3, 4 and 5, and resulting in a cata-
lytically active DNMT1 protein that lacked the PCNA and
part of the DMAP-binding domains (DNMT1DE36;
Figure 1A). Interestingly, the partial loss of 5mC
observed in DNMT1DE36 cells appeared speciﬁcally to
affect highly repetitive sequences, such as pericentromeric
Satellite2 and rDNA gene copies (1,9). In line with these
ﬁndings, the ﬁrst N-terminal region of DNMT1, encom-
passing the DMAP1 and PCNA domains, has been
Figure 1. Disruption of PCNA and DMAP1-binding domains of DNMT1 results in E-cadherin downregulation, nuclear translocation of b-catenin
and activation of b-catenin-dependent transcriptional signaling. (A) Schematic representation of full-length DNMT1 protein domain structure and
deletion mutants used in this study. DMAP1 domain, amino acids 1–120; PCNA domain, amino acids 163–174; NLS, nuclear localization signal
domain, amino acids 177–205; DNA replication foci-targeting domain, amino acids 331–550; ZnF, zinc ﬁnger region, amino acids 646–692; KEN,
KEN box (KENxxxR), amino acids 644–650; BAH1 and BAH2, bromo-adjacent homology domains, amino acids 755–880 and 972–1100, respect-
ively; catalytic domain, amino acids 1139–1616. Pictures are not drawn to scale. (B) Phase-contrast images of living cultured cells (left panels) and
Ca2+-dependent fast cell–cell aggregation assays in the presence or absence of a functional antibody against E-cadherin (Decma1) and the Ca2+-
chelating agent EDTA (right panel). These indicate a strong reduction of cell–cell adhesiveness in human HCT116 cells lacking PCNA and
DMAP1-binding domains of DNMT1 (DNMT1DE36), but not in parental cells (DNMT1+/+), or those lacking DNMT3b (DNMT3b/). The
meanSD of results from three experiments are shown. **Student’s t-test, P< 0.001. (C) Immunolocalization (red signal) of E-cadherin (upper
panels) and b-catenin (lower panels) in HCT116 DNMT1+/+, DNMT1DE36 and DNMT3b/ cells showing the extensive disorganization of
E-cadherin cell–cell contacts and nuclear translocation of b-catenin in DNMT1DE36 cells. Chromatin is counterstained with DAPI (blue signal).
Bars: 10 mm. (D) Semiquantitative analysis of protein expression by immunoblot showing total levels of E-cadherin, b-catenin, and SNAIL1 in
HCT116 DNMT1+/+, DNMT1DE36, and DNMT3b/ cells. b-tubulin protein content is included as a loading control. (E) Normalized Luciferase/
Renilla activities of reporter vectors transiently transfected in HCT116 DNMT1+/+, DNMT1DE36 and DNMT3b/ cells containing either TOP
multimerized promoter sequences recognized by b-catenin-Lef/Tcf complexes (upper panel), or the human cyclinD1 promoter (lower panel). The
activity of both reporters is signiﬁcantly higher in DNMT1DE36 cells. Analyses were performed in triplicate and the mean SD are shown.
**P< 0.001.
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associated with speciﬁc target recognition and localization
to AT-rich regions such as repetitive Line1 and satellite
sequences (10,11).
Reduction of catalytically competent forms of DNMT1
in HCT116 cells below a 20% threshold, compared with
normal DNMT1 expression, resulted in massive 5mC
demethylation, loss of cell viability and cell death after
mitotic catastrophe (7,8,12). Considered as a whole,
these results demonstrate that, in mammals, DNMT1
catalytic activity plays an essential role in the maintenance
of global DNA methylation patterns in the genome, and
that the maintenance of these patterns is required for
cellular viability.
Despite these observations, a potential role for DNMT1
in cell function independent of its catalytic activity has
been suggested. However, there is no clear evidence for
it and the matter remains controversial. In this sense, it
has been shown that depletion of DNMT1 can result in
activation of gene transcription by a DNA methylation-
independent mechanism (13). In contrast, it has recently
been claimed that catalytic DNA methyltransferase
activity is required for all biological functions of
DNMT1 (14). Here, we have used HCT116 cells express-
ing DNMT1DE36 hypomorphic alleles as a model to in-
vestigate the relevance of DMAP1, PCNA, and catalytic
domains for DNMT1 function. Because the zinc ﬁnger
factor SNAIL1 is the best know transcriptional repressor
of the E-cadherin gene (15,16), we have speciﬁcally studied
the SNAIL1-dependent downregulation of E-cadherin
that takes place in these cells in comparison to parental
HCT116 cells. Our results indicate that DMAP1 and
PCNA domains can support biological functions of
DNMT1 that are independent of its catalytic activity.
MATERIALS AND METHODS
Cell culture, expression vectors and transfections
Parental HCT116 cells (DNMT1+/+), HCT116 cells ex-
pressing an alternative spliced form of the DNMT1 gene
after deletion of exons 3–6 (DNMT1DE3–6) (6–8), HCT116
cells lacking both copies of the DNMT3b gene
(DNMT3b/–) and HCT116 cells expressing DNMT1DE3–6
and also lacking both copies of DNMT3b (DKO cells)
(17) were grown in DMEM under standard cell culture
conditions. Two clones of DNMT1DE3–6 and DNMT3b/–
cells were used throughout this study. Stable transfectants
of HCT116 cells expressing SNAIL1-shRNA or
EGFP-shRNA were obtained using pSuperior-shRNA
against SNAIL1 (18) or EGFP (19) and puromycin selec-
tion (1mg/ml) for 3 weeks. At least four independent clones
from each transfection were characterized. Samples for all
different types of experiments performed throughout this
study were collected in the exponential growth phase of
the cell cycle of each cell line.
A cDNA corresponding to full-length DNMT1
gene-coding sequence (+1/+4851) was obtained by
RT–PCR using speciﬁc oligonucleotides (Sequences of
PCR primers used in this study are shown in Supple-
mentary Table S1) from an mRNA pool puriﬁed from
parental HCT116 cells, cloned in pcDNA3.1A
(Invitrogen) or pRFP (Clontech) plasmids and sequenced.
From these plasmids, deletion mutants of full-length
DNMT1 lacking the catalytic domain (DNMT1Dcat; +1/
+3494), the catalytic and both BAH domains
(DNMT1DCat/BAH;+1/+2421) or the N-terminal region en-
compassing DMAP and PCNA domains (DNMT1DN;
+1469/+4851) were generated by PCR using speciﬁc
adapters. A 1226Cys>Val substitution (DNMT1mut) in the
catalytic domain was also generated using standard proto-
cols for site-directed mutagenesis.
A 1.6-kb fragment of the SNAIL1 50 upstream se-
quences was ampliﬁed by PCR from a human genomic
clone (Invitrogen) using speciﬁc oligonucleotides. This
human 50 upstream sequence of SNAIL1, as well as the
proximal E-cadherin (a gift from Dr F Van Roy,
University of Ghent, Belgium) and Cyclin D1 (a gift
from Dr A Mun˜oz, IIB-CSIC, Madrid, Spain) promoters,
or TOP/FOP constructs, containing multimerized wild-
type and mutated b-catenin/Lef1-binding sites (a gift
from H Clevers, Hubrecht Institute, Holland), respective-
ly, were all cloned into pGL2 Luciferase reporter plasmid
and sequenced. Luciferase activity of the aforementioned
constructs was measured using the Glo-Luciferase
reporter assay kit (Promega) and normalized to Renilla
activity in accordance with the manufacturer’s instruc-
tions. In all cases, 6 105 cells were transiently transfected
in triplicate using Lipofectamine reagent (Invitrogen) with
2 mg of the aforementioned plasmids.
For the extended biomolecular ﬂuorescence comple-
mentation assays (ExBiFC) (23), a full-length DNMT1
cDNA was cloned in the ExBiFC RFP/C-YFP plasmid
and a full-length SNAIL1 cDNA was cloned in the
ExBiFC CFP/N-YFP plasmid (a gift from R Brack-
Werner, GSF-National Research Center for Environment
and Health, Neuherberg, Germany). HCT116 cells grow-
ing on coverslips were transfected using Lipofectamine
reagent (Invitrogen) with 15 mg of the aforementioned
plasmids.
Immunological methods
Antibodies used in this study included: mouse anti-SNAIL1
(a gift from Dr I Virtanen, University of Helsinki, Finland),
mouse anti-DNMT1 (BD Pharmingen) mouse anti-b-
catenin (BD Transduction), mouse anti-ABC b-catenin,
detecting an active form of b-catenin dephosphorylated
on Ser37 or Thr41 (Upstate), rat anti-E-cadherin
(ECCD2), mouse anti-b-tubulin (Amersham) and rabbit
anti-myc epitope (Sigma). The secondary antibodies used
were HRP-coupled anti-rabbit, anti-mouse (Amersham)
and anti-rat (Pierce), and anti-mouse, anti-rat and anti-
rabbit coupled to either Cy2 or Cy3 (Jackson), as
indicated.
Coimmunoprecipitation, pull down, immunoblot and
immunolocalization experiments were performed essen-
tially as described elsewhere (9,20). For immunoblots,
HRP activity was detected using the ECL-
chemiluminescent kit (Amersham) in accordance with
the manufacturer’s instructions. Quantiﬁcation of the
Integrated Density of semiquantitative immunoblots was
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performed by using the Image J software (http://rsb.info
.nih.gov/ij).
After immunolocalization experiments or ExBiFC
plasmid transfection assays, samples were analyzed at
room temperature with either a ﬂuorescence microscope
(Axiophot; Zeiss) or a laser-scanning confocal microscope
(TCS-SP2-AOBS; Leica) equipped with HC PL APO CS
20NA 0.70, HCX PL APO CS 40NA 1.25, and HCX
PL APO Ibd BL 63NA 1.4 objective lenses. Images
were acquired with LCS Suite version 2.61 (Leica), and
were edited using the free GNU Image Manipulation
Program (http://www.gimp.org).
SPLIT-TEV detection DNMT1/SNAIL1 interactions
For SPLIT-TEV assays, constructs containing the SNAG
domain of SNAIL1 and either the DMAP1/PCNA or
catalytic domains of DNMT1 were engineered on
pBK-GCN4-N- and C-TEV plasmids as described (21).
Full-length SNAIL1 and DNMT1 coding sequences
were ampliﬁed by PCR and cloned in XbaI and NheI
sites of the GCN4 vectors. To isolate the SNAG domain
from SNAIL1, an extra NheI site was created by directed
mutagenesis (22), to eliminate the C-terminal coding
region beyond the SNAG domain. The same strategy
was used for the DMAP1/PCNA region of DNMT1.
For the catalytic domain of DNMT1, an XbaI site was
introduced in full-length DNMT1 to eliminate the
N-terminal region before the catalytic domain. All
deoxyoligonucleotides sequences are available upon
request. Constructs were checked by sequencing and
western blotting.
Different combinations of SPLIT-TEV constructs were
transfected into HeLa cells. In all cases, transfected com-
binations included the membrane-bound transcriptional
activator GV (TM-GV) and its target reporter containing
ﬁve GAL4 responsive elements (G5-Luc) driving a Renilla
luciferase gene (G5-Luc/pTK-RL). Both plasmids were
combined with different constructs including the N- or
C-terminal regions of the TEV protease fused to the
GCN4 coiled-coil region, to the SNAG domain from
SNAIL1, to the DMAP1/PCNA or to the catalytic
domain of DNMT1. Transfections were developed with
Lipofectamine and luciferase activity was measured as
described above.
Fast cell–cell aggregation assays
Cells grown to subconﬂuence were incubated at 37C in
0.25% trypsin without EDTA (Gibco) in the presence of
2mM CaCl2 to preserve Ca
2+-dependent cell–cell adhe-
sion. Detached cells were washed in PBS, resuspended in
2mM EDTA–PBS, and thoroughly pipetted to dissociate
cell–cell contacts. Isolated cells were washed in PBS and
30 103 cells were plated in T24 wells (Costar) in 400 ml of
either 2mM EDTA–PBS or 2mM CaCl2-PBS, or 2mM
CaCl2-PBS+0.2mg/ml of a functional antibody against
E-cadherin (Decma1; Sigma). Aggregation assays were
performed for 45min at 37C rotating at 85 rpm; the ag-
gregation index was calculated as the ratio 1 –N/N0, where
N and N0 are the numbers of particles at the end and the
beginning of the experiment, respectively. Particles were
counted in a Coulter Counter (Beckman). Experiments
were performed in triplicate and the mean  SD
calculated.
RT–PCR and qRT–PCR analysis
Total RNA from cell lines was extracted with Trizol
reagent (Invitrogen) and treated with DNaseI (Ambion).
An amount of 2 mg of RNA were used to obtain cDNA
using oligo(dT) primers and SuperScript Reverse
Transcriptase (Life Technologies). An amount of 100 ng
of cDNA were used for subsequent PCR experiments.
Speciﬁc primers (Sequences of PCR primers used in this
study are shown in Supplementary Table S1) were
designed between different exons, thereby avoiding
residual genomic DNA ampliﬁcation, for semiquantitative
or quantitative transcript detection of E-cadherin,
SNAIL1, and GAPDH using TaqExpand High Fidelity
(Roche) as described elsewhere (16,23,24).
ChIP assays
ChIP assays were performed as previously described
(9,20). Brieﬂy, before formaldehyde crosslinking, cells
were treated with 10mM dimethyl adipimidate (DMA)
0.25% DMSO in PBS for 45min. Chromatin was then
sheared to an average length of 0.25–1 kb. HDAC1 and
DNMT1 were immunoprecipitated with the aforemen-
tioned antibodies.
DNA methylation analysis
The DNA methylation status of promoter sequences of
E-cadherin and SNAIL1 genes was analyzed by bisulﬁte
sequencing (9) and DNA restriction with a methylation-
sensitive endonuclease followed by PCR. For bisulﬁte
genomic sequencing, both strands were sequenced and at
least 10 clones were analyzed per sequence. Supple-
mentary Table S1 shows all the PCR primers used in the
article.
RESULTS
Loss of E-cadherin-dependent cell–cell adhesion and
transcriptional-competent nuclear translocation of
b-catenin in DNMT1"E3–6 cells
Human HCT116 are epithelial cells showing high levels of
expression of DNMT1 and DNMT3b, but not of
DNMT3a or other components of the DNMT family
(6,17). These cells exhibited well-formed cell–cell contacts
and signiﬁcant Ca2+-dependency for cell–cell adhesion in
fast aggregation assays (Figure 1B). Using speciﬁc func-
tional antibodies able to efﬁciently inhibit E-cadherin-
mediated cell–cell adhesion (Decma1), we found that a
large fraction of Ca2+-dependent cell–cell adhesion in
HCT116 cells was supported by E-cadherin activity
(Figure 1B). Notably, HCT116 cells exclusively expressing
an alternative spliced form of the DNMT1 mRNA that
lacked exons 3–6 (DNMT1DE36 cells; two different clones
were used throughout this study, giving essentially equiva-
lent results) had a scattered phenotype and presented a
drastic downregulation of E-cadherin expression, which
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was associated with a signiﬁcant loss of Ca2+-dependent cell
adhesion (Figure 1B–D and Supplementary Figure S1). In
parallel with E-cadherin downregulation, DNMT1DE36
cells strongly re-expressed vimentin and ﬁbronectin, two
markers associated with epithelial–mesenchymal transi-
tions (Supplementary Figure S2). In contrast, complete
suppression of DNMT3b gene expression in HCT116
cells (DNMT3b/ cells; two different clones were used
throughout this study, giving essentially equivalent results)
had no statistically signiﬁcant effect on E-cadherin expres-
sion or on Ca2+-dependent cell adhesion (Figure 1B–D
and Supplementary Figure S1). These observations indi-
cate that the PCNA and part of the DMAP1 domains in
the N-terminal region of human DNMT1 protein (corres-
ponding to exons 3–6 in the DNMT1 gene) are involved in
regulating E-cadherin expression.
We also found that, concomitant with the down-
regulation of E-cadherin expression in DNMT1DE36
cells, b-catenin was released from cell–cell contacts and
translocated to the nucleus (Figure 1C). b-Catenin is an
essential component of the E-cadherin adhesion complex.
This protein is not only strictly required at the cell
membrane for E-cadherin-dependent cell–cell adhesion,
but also, equally importantly, is a central element of the
Wnt-signaling pathway. In resting conditions, b-catenin
released from cell–cell contacts is rapidly destroyed in
the cytoplasm by the ubiquitin/proteasome pathway.
However, upon canonical Wnt activation, b-catenin can
dissociate from E-cadherin complexes in the cell
membrane, and may be stabilized in the cytoplasm and
translocate to the nucleus, whereupon it promotes the ac-
tivation of target genes after binding to Lef/Tcf transcrip-
tion factors (25). Importantly, no changes in b-catenin
expression levels were observed in DNMT1DE36 cells
(Figure 1D). This observation indicates that nuclear-
translocated b-catenin can be metabolically stabilized
and transcriptionally competent in these cells. Therefore,
we next investigated the ability of released b-catenin to
activate Wnt/b-catenin targets by measuring the activity
of exogenous TOP-Luciferase reporters, which are specif-
ically recognized by b-catenin-Lef/Tcf complexes. As
expected, DNMT1DE36 cells showed signiﬁcantly greater
activation of Wnt/b-catenin reporter sequences than did
parental and DNMT3b/ cells (Figure 1E). We also
analyzed the activation of an exogenous reporter contain-
ing the CyclinD1 promoter, a direct gene target of
activated b-catenin-Lef/Tcf complexes (26,27). Strong ac-
tivation of the CyclinD1 reporter was observed in
DNMT1DE36 cells compared with parental DNMT1+/+
and DNMT3b/ cells (Figure 1E). These results imply
that DNMT1, but not DNMT3b, can potentially modulate
Wnt/b-catenin signaling by downregulation of E-cadherin
expression and the associated release of transcriptionally
competent b-catenin.
Downregulation of E-cadherin in DNMT1"E3–6 cells
depends on SNAIL1
The zinc ﬁnger factor SNAIL1 is perhaps the most potent
transcriptional repressor of the E-cadherin gene (15,16).
We found a detectable level of expression of SNAIL1
protein in HCT116 DNMT1+/+ cells, and equivalent
quantities in DNMT1DE36 and DNMT3b/ cells
(Figure 1D and Supplementary Figure S1). To evaluate
the importance of SNAIL1 in the E-cadherin
downregulation observed in DNMT1DE36 cells, we de-
signed a SNAIL1 knockdown experiment. We reasoned
that if SNAIL1 is fundamental in the repression of
E-cadherin and in the b-catenin nuclear translocation
observed in DNMT1DE36 cells, the siRNA-mediated de-
pletion of SNAIL1 in DNMT1DE36 cells should restore a
phenotype similar to that of parental HCT116 DNMT1+/+
cells. Indeed, we found that siRNA-mediated depletion of
SNAIL1 in DNMT1DE36 cells resulted in the strong
downregulation of metabolically stable, dephosphorylated
forms of b-catenin (Figure 2A and B). This was associated
with the almost complete nuclear exit and relocalization to
cell–cell contacts of b-catenin, and re-expression of
E-cadherin in the cell membrane (Figure 2A and B).
Equally important, Wnt/b-catenin transcriptional targets
are efﬁciently repressed in DNMT1DE36 cells after
siRNA-mediated depletion of SNAIL1 (Figure 2C).
These results demonstrate that SNAIL1 is the repressor
factor involved in the downregulation of E-cadherin in
DNMT1DE36 cells.
Downregulation of E-cadherin in DNMT1"E3–6 cells
occurs at the transcription level but does not involve
changes in SNAIL1 mRNA expression or in E-cadherin
and SNAIL1 promoter methylation
We next investigated the effect of the disruption of PCNA
and DMAP1 domains in both copies of the DNMT1 gene
on the activity of the E-cadherin promoter. We ﬁrst
examined the expression of the E-cadherin mRNA. As
shown in Figure 3A and B, E-cadherin levels were signiﬁ-
cantly reduced in DNMT1DE36 cells, suggesting that the
E-cadherin promoter is severely repressed in these cells
relative to parental DNMT1+/+ and DNMT3b/ cells.
To determine the effect of DNA methylation on this re-
pression, we examined by bisulﬁte sequencing and DNA
restriction with a methylation-sensitive endonuclease
followed by PCR the status of CpG methylation in the
E-cadherin promoter. Interestingly, no CpG methylation
was detected in the endogenous E-cadherin promoter in
parental HCT116 DNMT1+/+ cells, and no changes in
DNA methylation status occurred in DNMT1DE36 or
DNMT3b/ cells (Supplementary Figure S3). Analysis
of the activity of a non-methylated reporter containing
the human E-cadherin promoter revealed that its ac-
tivity was signiﬁcantly diminished in DNMT1DE36 cells
(Figure 3C), which suggests the existence of a fast-acting
molecular mechanism that efﬁciently represses the activity
of the exogenous E-cadherin promoter in these cells. In
cultured cells, the acquisition of a stable ‘de novo’ DNA
methylation mark, or the reversion of previously estab-
lished DNAmethylation imprinting, is a long-term process
requiring several rounds of DNA replication. Therefore,
the above results suggest that repression of E-cadherin in
DNMT1DE36 cells is a DNA-methylation-independent
event at the E-cadherin promoter level.
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Analysis of DNA methylation at CpG sites revealed
that the SNAIL1 promoter was equally unmethylated in
parental HCT116 DNMT1+/+, as well as in DNMT1DE36
and DNMT3b/ cells (Supplementary Figure S3).
Furthermore, all these cell lines showed similar levels of
SNAIL1 mRNA expression and an exogenous Luciferase
reporter directed by the human SNAIL1 promoter showed
similar activity in all tested cell lines (Figure 3A–C). Taken
together, these observations suggest that a DNMT1/
SNAIL1-dependent mechanism is responsible for the re-
pression of the E-cadherin gene in DNMT1DE36 cells and
that this mechanism occurs in the absence of noticeable
changes in DNA methylation. Since HCT116 DNMT1+/+,
DNMT1DE36 and DNMT3b/ cells have signiﬁcantly
different E-cadherin expression levels and an approxi-
mately equivalent level of expression of SNAIL1, the
above results imply that the PCNA and/or DMAP1
domains of DNMT1 are implicated in the
post-transcriptional regulation of SNAIL1 function. This
mechanism can also efﬁciently modulate b-catenin-
dependent transcriptional activity.
The DMAP1 and PCNA domains of DNMT1 are
sufﬁcient to restore E-cadherin expression in
DNMT1"E3–6 cells
We next investigated the relevance of the PCNA/DMAP1
region and the requirement for the catalytic domain of
DNMT1 in the DNMT1-dependent regulation of
E-cadherin observed in DNMT1DE36 cells. To this end,
we ﬁrst reintroduced a cDNA coding for full-length
DNMT1, and thus PCNA and DMAP1-coding regions,
into DNMT1DE36 cells. We found that expression of an
exogenous full-length DNMT1 was sufﬁcient to restore
E-cadherin expression and protein localization at cell–
cell contacts, and to force the relocalization of b-catenin
Figure 2. SNAIL1 is directly involved in the regulation of E-cadherin expression and nuclear translocation of b-catenin in DNMT1DE36 cells. (A)
Immunolocalization analyses showing re-expression of E-cadherin and relocalization of b-catenin from the cell nucleus to newly formed cell–cell
contacts after siRNA-mediated depletion of SNAIL1 in DNMT1DE36 cells. Stable transfections of shRNA-EGFP or Mock vectors were performed
as controls. At least three stable clones or transient transfections were analyzed. Bar: 10 mm. (B) siRNA-mediated depletion of SNAIL1 in cells
expressing DNMT1DE36 by stable transfection of the corresponding shRNAs. Protein expression by immunoblot indicates that E-cadherin is
re-expressed after depletion of SNAIL1. Similarly, levels of a metabolically stabilized form of b-catenin, dephosphorylated on Ser37 or Thr41
(b-catenin-ABC), are strongly reduced after SNAIL depletion in DNMT1DE36 cells. No signiﬁcant changes of DNMT1 protein expression levels
were observed. Three different siRNA-transfected clones are represented. b-tubulin expression was used as loading control. (C) Normalized
Luciferase/Renilla activities in HCT116 DNMT1DE36 control and siSNAIL1 cells, after transient cotransfection of reporter vectors containing
multimerized promoter sequences recognized by b-catenin-Lef/Tcf complexes (upper) or cyclin D1 promoter (lower). Analyses were performed in
triplicate and the mean SD are shown. **P< 0.001.
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to the cell membrane in DNMT1DE36 cells (Figure 4A).
By analyzing the presence of exons 1–6, which correspond
to the DMAP1 and PCNA coding regions, compared with
exons 32–34, which correspond to a part of the catalytic
domain-coding region of the DNMT1 gene, we conﬁrmed
the absence of DMAP1 and PCNA full domains in
DNMT1DE36 cells, as expected, and the re-expression of
both domains after full-length DNMT1 transfection
(Figure 4D). Importantly, exogenous transcriptional
b-catenin/Lef/Tcf targets were efﬁciently repressed by
re-expression of full-length DNMT1 (Figure 4B).
DNMT1DE36 cells were also transfected with deletion
forms of DNMT1 cDNA lacking the catalytic domain
(DNMT1DCat), or the catalytic and BAH domains
(DNMT1DCat/BAH) (Figure 1A). Both deletion mutants were
located in the cell nucleus (Supplementary Figure S4) and
efﬁciently restored the expression of exons 1–6 of the
DNMT1 gene (Figure 4B). Taking into account the experi-
mental design of this assay, it is assumed that the forced
re-expression of exons 1–6 of DNMT1, coding for the
PCNA and DMAP1 regions of the protein, resulted
from the expression of the exogenous DNMT1DCat and
DNMT1DCat/BAH isoforms (lacking the catalytic domain)
and not from the endogenous DNMT1DE36 isoform
(lacking exons 3–6). Notably, re-expression of exons 1–6
of DNMT1 in these experimental conditions was able
to efﬁciently induce E-cadherin expression at mRNA
(Figure 4B) and protein (Figure 4C) levels, promoting a
signiﬁcant reduction of metabolically stabilized b-catenin
(Figure 4C) and a concomitant repression of exogenous
Wnt/b-catenin transcriptional targets (Figure 4D). The re-
pression activity on Wnt/b-catenin transcriptional targets
can be associated to a functional sequestering of b-catenin
at the cell membrane after E-cadherin re-expression. These
results indicate that the catalytic domain of DNMT1 is
dispensable for the regulation of E-cadherin transcription
in DNMT1DE36 cells. In contrast, PCNA and DMAP1
domains appear to be directly involved in the control of
E-cadherin expression.
To further demonstrate the importance of DMAP1 and
PCNA domains in the regulation of E-cadherin expres-
sion, we have used DNMT1DE36 cells with a combined
somatic deletion of both copies of the DNMT3b gene
(DNMTDKO cells). These cells exhibited a loss of Ca2+-
dependent cell–cell adhesion, a drastic downregulation of
E-cadherin, a nuclear translocation of b-catenin and an
activation of b-catenin-dependent transcriptional activity
which closely resembles the phenotype observed in
DNMT1DE36 cells, compared with parental HCT116
cells (Supplementary Figure S5). Strikingly, this pheno-
type is fully restored after reintroduction of full-length
DNMT1 (Supplementary Figure S5). These results high-
light the relevance of DMAP1 and PCNA domains of
DNMT1 in the regulation of E-cadherin expression and
b-catenin localization and transcriptional activity.
The DMAP1 and PCNA domains of DNMT1 are
required to interact with SNAIL1 and can regulate
the binding of SNAIL1 to the E-cadherin promoter
To gain further insight into the molecular mechanism
underlying the inhibition of E-cadherin expression that
takes place in DNMT1DE36 cells, we investigated the po-
tential association of SNAIL1 with the E-cadherin
promoter using ChIP assays. We found that SNAIL1 is
physically associated with the E-cadherin promoter in
DNMT1DE36 cells, but not in parental DNMT1+/+ or
DNMT3b/ cells (Figure 5A), in close agreement
with E-cadherin mRNA regulation in these cell lines
(Figure 3A and B). Our previous work has shown that
SNAIL1 can interact and recruit the histone deacetylase
modiﬁer HDAC1 to exert its repressor activity on the
E-cadherin promoter (20). Therefore, we also investigated
the association of HDAC1 with the E-cadherin promoter
in our cell system. As expected, HDAC1 was speciﬁcally
bound to the E-cadherin promoter in DNMT1DE36 cells,
but not in parental DNMT1+/+ or DNMT3b/ cells
(Figure 5A). In addition, no interaction of DNMT1 with
the E-cadherin promoter was detected in neither
DNMT1+/+, DNMT1DE36 or DNMT3b/ cells, but as-
sociation of DNMT1 to Satellite 2 repetitive sequences
Figure 3. Disruption of PCNA and DMAP1-binding domains of
DNMT1 induces E-cadherin gene repression at the transcriptional
level in the absence of changes in SNAIL1 expression.
(A) Semiquantitative analysis of mRNA expression by RT–PCR of
the indicated genes in HCT116 DNMT1+/+, DNMT1DE36 and
DNMT3b/ cells. A signiﬁcant and repetitive reduction of
E-cadherin mRNA is observed in DNMT1DE36 cells. No differences
are observed in total levels of SNAIL mRNA. Results shown are rep-
resentative of at least three independent experiments. (B) Quantitative
analysis of E-cadherin mRNA expression by qRT–PCR in HCT116
DNMT1+/+, DNMT1DE36 and DNMT3b/ cells. Relative expression
levels are normalized to actin expression. Results are representative of
those from three experiments. (C) Normalized Luciferase/Renilla
activities of reporter vectors transiently transfected in HCT116
DNMT1+/+, DNMT1DE36 and DNMT3b/, containing either the
human E-cadherin promoter (upper panel) or the human SNAIL11
promoter (lower panel). Reduced E-cadherin promoter activity is
observed in DNMT1DE36 cells, while no changes are observed in the
activity of the SNAIL1 promoter. Analyses were performed in triplicate
and the mean SD are shown. **P< 0.001.
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occurred in DNMT1+/+ and DNMT3b/ but not in
DNMT1DE36 cells (Figure 5A). These results indicate
that deletion of the DMAP1 and PCNA domains of
DNMT1 is sufﬁcient to promote the recruitment of
SNAIL1/HDAC1 complexes to the E-cadherin promoter
in DNMT1DE36 cells in a process that seems to be inde-
pendent of the association of DNMT1 to this promoter
region. The recruitment of Poly-comb repressors (EZH2
and Suz12) was not observed.
In this context, we hypothesized that DNMT1 could
bind SNAIL1 to alter the association of this repressor
with the E-cadherin promoter and/or to inhibit the forma-
tion of SNAIL1/HDAC complexes. To test this, we per-
formed a series of coimmunoprecipitation assays, which
showed that endogenous DNMT1 and SNAIL1 can be
associated in vivo (Figure 5B). As expected, the interaction
of DNMT1 and SNAIL1 was disrupted in DNMT1DE36
cells (Supplementary Figure S6). Further assays, using dif-
ferent mutant forms of DNMT1 to pull-down endogenous
SNAIL1, showed that the DMAP1/PCNA region of
DNMT1 is required to interact with SNAIL1. Thus, an
exogenous full-length form of DNMT1, as well as mutant
forms of DNMT1 lacking the catalytic domain
(DNMT1Cat), or the catalytic and both BAH domains
(DNMT1Cat/BAH), but containing the DMAP1 and
PCNA domains, and a 1226Cys>Val substitution
(DNMT1mut) in the catalytic domain (Figure 1A), were
all able to bind to SNAIL1 (Figure 5C). In contrast, a
mutant DNMT1 form lacking the N-terminal region con-
taining DMAP1 and PCNA domains (DNMT1N) was
unable to interact with SNAIL1 in these assays (Figure 5C).
To further study the interaction between DNMT1 and
SNAIL1, we used the SPLIT-TEV method (21). In this
technique, domains of interest are tagged as fusion
proteins to either the N- or C-terminal regions of the
TEV protease. TEV activity is restored only if interaction
of tagged domains takes place. Once activated, reconsti-
tuted TEV protease can then operate on the second
branch of the SPLIT-TEV method, namely, an exogenous
transcription factor that is anchored to the cell membrane
through a TEV target sequence (TM-GV). This exogenous
transcription factor directs the synthesis of Luciferase
from a GAL4 artiﬁcial promoter. Once TEV protease is
reconstituted, membrane-bound TM-GV is released and
the activity of the released transcription factor is measured
as luciferase activity.
Figure 4. PCNA and DMAP1 domains of DNMT1, but not its catalytic region, are directly involved in the regulation of E-cadherin expression and
nuclear translocation of b-catenin in DNMT1DE36 cells. (A) Immunolocalization analyses showing re-expression of E-cadherin and relocalization of
b-catenin from the cell nucleus to newly formed cell–cell contacts after reintroduction of full-length DNMT1 in DNMT1DE36 cells. At least three
stable clones or transient transfections were analyzed. Bar: 10 mm. (B) Upper panel: Semiquantitative analysis of mRNA expression by RT–PCR of
exons 1–6 and exons 32–34 of the DNMT1 gene in DNMT1DE36 cells transfected with full-length DNMT1 cDNA (DNMT1), or deletion forms of
DNMT1 cDNA lacking the catalytic domain (DNMT1DCat), or the catalytic and BAH domains (DNMT1DCat/BAH). Results are representative of two
different experiments. Actin expression was used as a loading control. Lower panel: Quantitative analysis of E-cadherin mRNA expression by qRT–
PCR in DNMT1DE36 cells transfected with full-length DNMT1 cDNA (DNMT1), or deletion forms of DNMT1 cDNA lacking the catalytic domain
(DNMT1DCat), or the catalytic and BAH domains (DNMT1DCat/BAH). Relative expression levels are normalized to actin expression. Results are
representative of three different experiments and the mean SD are shown. **P< 0.001. (C) Semiquantitative analysis by immunoblot of E-cadherin,
b-catenin and b-catenin-ABC protein expression in DNMT1DE36 cells transfected with full-length DNMT1 cDNA (DNMT1), or deletion forms of
DNMT1 cDNA lacking the catalytic domain (DNMT1DCat), or the catalytic and BAH domains (DNMT1DCat/BAH). Results are representative of two
different experiments. b-tubulin expression was used as a loading control. (D) Normalized Luciferase/Renilla activity of reporter vector containing
multimerized promoter sequences recognized by b-catenin-lef/tcf complexes in DNMT1DE36 cells transiently transfected with full-length DNMT1
cDNA (DNMT1), or deletion forms of DNMT1 cDNA lacking the catalytic domain (DNMT1DCat), or the catalytic and BAH domains (DNMT1DCat/
BAH). Analyses were performed in triplicate and the mean SD are shown. **P< 0.001.
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In agreement with the results described above, we found
a positive interaction in the SPLIT-TEV assay when
full-length SNAIL1 and DNMT1 proteins were tested
(data not shown). Therefore, we next studied the speciﬁc
interaction of the SNAG domain from SNAIL1 with
either the DMAP1/PCNA or the catalytic (CAT)
domains of DNMT1 (Figure 5D). We found that SNAG
and DMAP1/PCNA domains can strongly interact with
each other, using either the N- or the C-terminal con-
structs (Figure 5D). In contrast, none of these domains
showed signiﬁcant interactions with the CAT domain
(Figure 5D). We also found that a DNMT1 construct
lacking the N-terminal DMAP1 and PCNA domains
(DNMT1N) was also unable to bind the SNAG
domain (Figure 5D). These results demonstrate that the
SNAG domain of SNAIL1 can physically interact with
the PCNA/DMAP1 domains of DNMT1.
Consistent with these results, confocal microscopy
immunolocalization assays also indicated that DNMT1
and SNAIL1 can co-localize in discrete positions in the
cell nucleus of DNMT1+/+ cells (Figure 6A) but not in
DNMT1DE36 cells (Supplementary Figure S6). To
further demonstrate the co-localization of DNMT1 and
SNAIL1 in the nuclear compartment, a set of extended
biomolecular ﬂuorescence complementation assays
(ExBiFC) (28) were performed in HCT116 cells. In this
experimental approach, proteins under study are tagged
either with red ﬂuorescent protein (RFP) fused to the
C-terminal fragment of the yellow ﬂuorescent protein
(C-YFP) (here, full-length DNMT1) or with cyan
Figure 5. The DMAP and PCNA domains of DNMT1 are required to interact with SNAIL1 and can regulate the association of SNAIL1 with the
E-cadherin promoter. (A) Chromatin immunoprecipitation (ChIP) analysis of the interaction of SNAIL1, DNMT1 and HDAC1 with the E-cadherin
promoter in HCT116 DNMT1+/+, DNMT1DE36 and DNMT3b/ cells, showing strong association of SNAIL1 and HDAC1 speciﬁcally in
DNMT1DE36 cells. Association of DNMT1 with Satellite 2 repetitive sequences (lower panels) was used as control. Results are representative of
two experiments. (B) Coimmunoprecipitation analysis showing the interaction of SNAIL1 and DNMT1 in protein extracts of HCT116 cells after
independent immunoprecipitation of either endogenous DNMT1 (upper panels) or endogenous SNAIL1 (lower panels). Results are representative of
three experiments. (C) Pull-down assays showing the interaction of endogenous SNAIL1 with exogenously expressed full-length DNMT1 or deletion
lacking the catalytic domain (DNMT1DCat), the catalytic and both BAH domains (DNMT1DCat/BAH) or the N-terminal region encompassing DMAP
and PCNA domains (DNMT1DN). A 1226Cys>Val substitution (DNMT1mut) in the catalytic domain was also used. Results are representative of two
different experiments. (D) Demonstration of a direct interaction of the SNAG domain of SNAIL1 with the DMAP1/PCNA domains of DNMT1 by
the SPLIT-TEV method. The graph shows the relative luciferase activity of different combinations of construct transfections as indicated. As a
positive control for full reporter activation to compare different experiments, a combination of the N- and C-terminal regions of the TEV protease
fused to the GCN4 coiled-coil region in the presence of the membrane-bound transcriptional activator GV (TM-GV) was considered as 100%
luciferase activity (GCNA4-N+C). On the opposite, luciferase activity in the presence of the membrane-bound transcriptional activator GV but in the
absence of TEV activity was considered as background level (TM-GV). Combinations of either N- or C-terminal constructs of the SNAG domain of
SNAIL1 with either N- or C-terminal constructs of DMAP1/PCNA domains, but not with the catalytic (CAT) domain, of DNMT1 showed a
signiﬁcant and strong activation of the luciferase activity reporter. The meanSEM of three different experiments performed in triplicate is
represented.
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ﬂuorescent protein (CFP) fused to the N-terminal of YFP
(N-YFP) here, SNAIL1. Co-localization of both target
proteins is revealed by a unique YFP emission. Our
results have consistently shown that exogenously trans-
fected DNMT1 (revealed as RFP emission) and SNAL1
(revealed as CFP emission)-tagged proteins were
homogenously distributed in the nuclear compartment,
but co-localization of both proteins mainly occurred in
discrete locations (Figure 6B and an additional example
is shown in Supplementary Figure S7A). Interestingly, no
YFP emission was detected when a mutant DNMT1 form
lacking the DMAP1 and PCNA domains (DNMT1N)
was assessed (Supplementary Figure S7b). The described
interaction between DNMT1 and SNAIL1 was not
restricted to cancer cells, but it was also observed by
co-immunoprecipitation experiments in human embryonic
kidney cells (Supplementary Figure S8). Overall, the
above observations strongly suggest that DNMT1 and
SNAIL1 can interact to form a macromolecular complex
in the cell nucleus.
DISCUSSION
The existence of functional roles for DNMT1 independent
of its catalytic activity as a DNA methylating enzyme is a
provocative but difﬁcult to prove hypothesis. The ideal
aprioristic system to analyze the non-catalytic function
of DNMT1 (and, by extension, of any other enzyme) is
Figure 6. DNMT1 and SNAIL1 can interact in the cell nucleus. (A) Direct immunoﬂuorescence analysis of the colocalization of SNAIL1 and
DNMT1 in the nucleus of HCT116 cell. SNAIL1 (red signal) is distributed in discrete spots in the cell nucleus, and colocalizes with DNMT1 (green
signal; arrow) in speciﬁc locations (yellow signal; arrow heads). The insert shows an enlarged view of the area of the region demarcated by the white
square. Images are of 0.1-mm-thick sections in the z-plane obtained by confocal microscopy. Bar: 5 mm. (B) Extended biomolecular ﬂuorescence
complementation assays (ExBiFC) to demonstrate the interaction of DNMT1 and SNAIL1 in the cell nucleus. DNMT1 was tagged with red
ﬂuorescent protein (RFP) fused to the C-region of the yellow ﬂuorescent protein (C-YFP) while SNAIL1 was tagged with cyan ﬂuorescent
protein (CFP) fused to the N-region of YFP (N-YFP). Both constructs were expressed in HCT116 cells. Interaction of DNMT1-RFP and
SNAIL1-CFP entailed the association of C- and T-regions of YFP and was revealed by the yellow emission of the whole protein. Upper panels:
Only cells expressing DNMT1-RFP+C-YFP and SNAIL1-CFP+N-YFP showed the emission of N+C-YFP (yellow arrowheads). Cells expressing
DNMT1-RFP+C-YFP but not SNAIL1-CFP+N-YFP did not show yellow emission (white arrowheads). Bars: 10 mm. Lower panels: Enlarged
images showing cells expressing DNMT1-RFP+C-YFP and SNAIL1-CFP+N-YFP. Both tagged proteins showed a homogeneous distribution
pattern in the cell nucleus. In contrast, the yellow emission corresponding to the N+C-YFP fusion was located in discrete regions of the nuclear
compartment. Bars: 5mm.
Nucleic Acids Research, 2011, Vol. 39, No. 21 9203
a knockin of a catalytically inactive enzyme. However, for
this approach to be unequivocally informative the
complete elimination of the endogenous full-length
enzyme is formally required, since all the non-catalytic
domains of the endogenous protein can unmask the
effects of the non-catalytic domains of the exogenous
mutant protein. Unfortunately, such an approach is un-
attainable in the case of DNMT1, since deletion of this
protein inevitably results in cell death and this effect is not
reversed by the introduction of non-catalytic domains of
DNMT1. In these conditions, the use of a cell line express-
ing a mutant form of DNMT1 lacking PCNA and
DMAP1 domains can be consider as a valid system to
investigate the role of both domains in different cellular
processes. Herein, we have speciﬁcally investigated the
SNAIL1-dependent regulation of E-cadherin, an event
that occurs in a DNA methylation-independent context
in these cells.
We have shown that disruption of the PCNA and
DMAP1 domains of DNMT1 protein in human
HCT116 cells induces signiﬁcant repression of the
E-cadherin gene. We have demonstrated that SNAIL1 is
required for E-cadherin repression in DNMT1DE36 cells.
A strong interaction of SNAIL1 with the E-cadherin
promoter, associated with transcriptional repression, is
induced in DNMT1DE36 cells. E-cadherin repression in
DNMT1DE36 cells promotes b-catenin nuclear transloca-
tion and activation of b-catenin-dependent transcription,
indicating that DNMT1 is a potential modulator of Wnt/
b-catenin signaling and may be directly involved in epithe-
lial–mesenchymal transitions.
E-cadherin downregulation in DNMT1DE36 cells
occurs in the absence of changes in the DNA methylation
patterns of E-cadherin or SNAIL1 promoters.
Modulation of gene activity through DNMT1 in the
absence of changes in the pattern of DNA methylation
has been described in other cell systems (28,29). The
basis for this mechanism of gene repression mediated by
DNMT1 is the interaction with, and recruitment of,
histone modiﬁers, such as HDACs, to speciﬁc DNA se-
quences, and the subsequent shift of chromatin structure
to a closed, inactive conformation. Consistent with this
explanation, our previous work indicated that SNAIL1
interacts with HDAC1/2 to repress the E-cadherin
promoter (20). Similarly, we have reported here that
HDAC1, in parallel with SNAIL1, is associated with the
E-cadherin promoter in DNMT1DE36 cells, but not in
DNMT1+/+ or DNMT3/ cells, in which E-cadherin is
strongly expressed.
Taken as a whole, these observations are consistent with
a model in which DNMT1 can modulate the activity of
the E-cadherin promoter in a DNA methylation-
independent manner. This could happen by direct inter-
action with SNAIL1 through the N-terminal region,
which would thereby prevent the association of this tran-
scriptional repressor with the E-cadherin promoter. It
could also result from the interaction with HDAC1/2,
which would prevent association of these chromatin modi-
ﬁers with SNAIL1 and, consequently, with the E-cadherin
promoter. It is even possible that both of these actions are
combined in a dual mechanism. Thus, the presence of
DNMT1 in epithelial cells may be associated with
E-cadherin expression and cell survival, while N-terminal
or complete deletion of DNMT1 is associated with
E-cadherin loss and subsequent activation of epithelial–
mesenchymal transition or cell death programs. This is
highly consistent with the central role of E-cadherin in
the two processes.
Interestingly, the expression of mouse Dnmt1 isoforms
resulting from alternative splicing in the N-terminal region
of the Dnmt1 gene, corresponding to exons 2–4, is a rela-
tively common phenomenon that occurs during muscle
differentiation (30) and oogenesis (31), as well as in
germinal (32,33) and somatic (34) adult tissues. Isoforms
of human DNMT1 affecting exons 2–4 have also been
detected in adult cells and tissues (35,36). In this context,
it is reasonable to speculate that alternative splicing that
affects N-terminal exons of the DNMT1 gene in mammals
and thereby accurately controls PCNA and DMAP1
domain expression can be an important element in the
regulation of DNMT1 function. In the same way, proteins
interacting with the DMAP1 and PCNA domains of
DNMT1 may have important roles in regulating
DNMT1 activity.
In conclusion, the results presented here indicate that
DNMT1 can have biological functions in the cell nucleus
that are independent of its enzymatic activity. These func-
tions are achieved mainly through the establishment of a
broad network of interactions with different nuclear
factors. In support of this, we report a novel mechanism
by which DNMT1 can maintain active gene expression of
E-cadherin after inhibitory binding to a complex of
SNAIL1 containing repressor proteins. Our results high-
light the importance of DNMT1 activity in the absence of
DNA methylation, enlarging the concept of epigenetic
modes of gene expression regulation.
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